Recombinant antibody production employs Chinese hamster ovary (CHO) cells due to their robustness in expressing complex proteins. Enhancing these processes involves adjusting various parameters, including cell line engineering, media composition, and bioreactor conditions. A key goal is to amplify antibody titer while reducing production expenses a